drugset / Trial / NCT00478855
Tazocin Intervention Study
Non-randomizedSingle-groupOpen-labelPrevention
Summary
1. To determine the value of using piperacillin/tazobactam in reducing the cases of extended spectrum beta lactamases (ESBL) producing E. coli or K. pneumoniae colonization and infection. 2. To determine the acquisition rate of ESBL producing E. coli or K. pneumoniae, both pre-and post-intervention in the selected medical centers.
Timeline
- Start
- 2006-09
- Primary completion
- —
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Piperacillin | Small molecule | — | — |
| Subject | Tazobactem | Unknown | — | — |